Health · STAT+: Why benchmarking clinical LLMs from OpenEvidence, Doximity is complicated
Benchmarking clinical LLMs from OpenEvidence and Doximity proves complicated
Why it matters
As clinical chatbots proliferate in healthcare settings, the difficulty of establishing reliable performance benchmarks raises questions about how providers and patients can evaluate these AI tools before adoption.
The brief
Evaluating clinical large language models from companies like OpenEvidence and Doximity presents significant challenges, according to a new analysis.[1][2] The complexity stems from the specialized nature of medical knowledge and the high stakes of clinical decision-making, where standard AI benchmarks may not capture real-world performance.[3] The benchmarking discussion comes amid broader debates about AI's role in medicine, with healthcare professionals expressing concerns about how these tools affect clinical practice.[4] Nurses warn that clinical AI threatens both their jobs and patient safety, while physicians argue that AI systems reflect an ongoing erosion of medical judgment rather than enhancing professional autonomy.[5][6][7]
What we don’t know yet
- OpenEvidence and Doximity are companies that have developed clinical large language models. Not yet confirmed by an independent source.
- Evaluating clinical large language models presents significant challenges. Not yet confirmed by an independent source.
- Standard AI benchmarks may not capture real-world performance of clinical LLMs. Not yet confirmed by an independent source.
- Healthcare professionals have expressed concerns about how clinical AI tools affect clinical practice. Not yet confirmed by an independent source.
Quick answers
- What happened?
- Evaluating clinical large language models from companies like OpenEvidence and Doximity presents significant challenges, according to a new analysis. The complexity stems from the specialized nature of medical knowledge and the high stakes of clinical decision-making, where standard AI benchmarks may not capture real-world performance. The benchmarking discussion comes amid broader debates about AI's role in medicine, with healthcare professionals expressing concerns about how these tools affect clinical practice. Nurses warn that clinical AI threatens both their jobs and patient safety, while physicians argue that AI systems reflect an ongoing erosion of medical judgment rather than enhancing professional autonomy.
- Why does it matter?
- As clinical chatbots proliferate in healthcare settings, the difficulty of establishing reliable performance benchmarks raises questions about how providers and patients can evaluate these AI tools before adoption.
- How was "Benchmarking clinical LLMs from OpenEvidence and Doximity proves complicated" verified?
- Citelink grounded this brief in 3 sources, including STAT News. Every claim links to its citation in the sources list below.
Grounding — every claim checked against sources
of 7 grounded0OpenEvidence and Doximity are companies that have developed clinical large language models.
Evaluating clinical large language models presents significant challenges.
Standard AI benchmarks may not capture real-world performance of clinical LLMs.
Healthcare professionals have expressed concerns about how clinical AI tools affect clinical practice.
Nurses have warned that clinical AI threatens their jobs.
Nurses have warned that clinical AI threatens patient safety.
Physicians argue that AI systems reflect an erosion of medical judgment.
Don't take our word for it
Run any claim in this Brief through Citelink's verification engine yourself.
Sources
How this brief was made
Citelink’s automated pipeline wrote this summary from the 3 sources listed above, then checked each claim against them before publishing. Briefs are not individually reviewed by a person before they go live, so read the original reporting for the full story.
Spotted an error? Request a correction · Corrections policy